Dr Felix Beacher, an expert in AI for predicting clinical trials, precision medicine, and drug development, discusses the potential of machine learning to develop tools for precision medicine and revolutionize drug development. Topics include the problems with the current clinical trial system, the role of AI in predicting treatment responses, the challenges of integrating AI workflows into clinical trial processes, and an inexpensive AI approach for diagnosing Parkinson's disease.
